
Tate & Lyle reported 1% revenue growth by volume-led performance in the six months to September 30, 2026, with volume/mix up 3% and EBITDA down 8%, in line with management expectations. It maintained full-year guidance, reported £100 million in free cash flow, and said its $200 million five-year productivity program remains on track; the planned acquisition by Ingredion is awaiting regulatory and antitrust processes.
The results describe a broad food-ingredients business rather than a specific feed commodity supply or demand change, so no clear near-term feed-market price implication is evident.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.